Genetic Regulation of Surfactant Deficiency

CompletedOBSERVATIONAL
Enrollment

525

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Respiratory Distress Syndrome, Newborn
Interventions
DRUG

Nutrient

We administer stable isotopically labeled precursors of surfactant phospholipids (\[1-13C1\] acetate) and of surfactant protein-B (\[5,5,5-2H3\] leucine) to infants with neonatal respiratory distress syndrome. Using mass spectrometry, we measure incorporation of stable isotopically labeled precursors in tracheal aspirates and compare surfactant phospholipid and surfactant protein-B turnover.

Trial Locations (1)

63110

St. Louis Children's Hospital, St Louis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Washington University School of Medicine

OTHER

NCT00828243 - Genetic Regulation of Surfactant Deficiency | Biotech Hunter | Biotech Hunter